UK ARM OF INDIA'S DABUR PHARMA GETS USFDA NOD FOR ANTI-CANCER DRUG.
Publication: AsiaPulse News
Publication Date: 29-NOV-06
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
MUMBAI, Nov 29 Asia Pulse - Dabur Pharma (BSE:532545) said on Tuesday its UK-based wholly owned subsidiary Dabur Oncology Plc has been granted Abbreviated New Drug Application (ANDA) approval for its anti-cancer Paclitaxel molecule by US Food and Drug Administration.
Dabur Pharma, in a communique to the Bombay Stock...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
